Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cansu Cimen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2023
Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE GroupAntonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Cancer Discovery|March 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant SettingMansi Saxena, Thomas U Marron, Julia Kodysh, et al.
Cell|June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFsShira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 31, 2023
Pseudomonasaeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE GroupAntonio Oliver, Estrella Rojo-Molinero, Jorge Arca-Suarez, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Cancer Discovery|March 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant SettingMansi Saxena, Thomas U Marron, Julia Kodysh, et al.
Cell|June 25, 2021
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFsShira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, et al.
Science Translational Medicine|June 15, 2022
Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccineMathieu Gigoux, Morten O Holmström, Roberta Zappasodi, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 2026
Emulating a target trial of early compared with late initiation of appropriate antibiotic therapy for hospital-acquired monobacterial Gram-negative bloodstream infectionsAbdullah T Aslan, Yukiko Ezure, Elif Seren Tanriverdi, et al.
Pageof 4